{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:02:19Z","timestamp":1784044939488,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Beijing Municipal Natural Science Foundation","award":["7202192"],"award-info":[{"award-number":["7202192"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Hepatoblastoma (HB) is a common liver malignancy in children. Our previous study has disclosed the crucial role of STAT3 (signal transducer and activator of transcription 3) in HB.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Aim of the study<\/jats:title>\n<jats:p>Present study was designed to study the circular RNA (circRNA) STAT3 in HB.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Gel electrophoresis revealed the circular characteristics of circ-STAT3. Function assays like EdU, transwell and sphere formation assay disclosed the function of circ-STAT3 in HB cells. Mechanism assays including ChIP, RIP, RNA pull down assay demonstrated the macular mechanism underlying circ-STAT3.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Circ_0043800, which was originated from STAT3, was up-regulated in HB tissues and cells. More importantly, silencing of circ-STAT3 led to the inhibition on HB cell growth, migration and stem-cell characteristics. Circ_0043800 was predominantly located in the cytoplasm of HB cells. Then, circ_0043800 was found to up-regulate STAT3 via sponging miR-29a\/b\/c-3p. Besides, we identified that STAT3 overexpression partially rescued silenced circ_0043800, while miR-29a\/b\/c-3p inhibition completely rescued silenced circ_0043800 on HB cellular biological behaviors. Subsequently, Gli2 (GLI family zinc finger 2) was identified as another target of miR-29a\/b\/c-3p. Circ_0043800 served as a competing endogenous RNA (ceRNA) to up-regulate both Gli2 and STAT3 via sponging miR-29a\/b\/c-3p. Moreover, we figured out that Gli2 overexpression completely rescued silenced circ_0043800 on HB cell malignant behaviors. After that, we discovered that Gli2 transcriptionally activated circ_0043800. The in-vivo assays further revealed that circ_0043800 promoted HB tumor growth by up-regulation of Gli2 and STAT3.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Gli2-induced circ_0043800 served as the ceRNA to promote HB by up-regulation of STAT3 and Gli2 at a miR-29a\/b\/c-3p dependent manner.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13046-020-01598-8","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T14:47:12Z","timestamp":1591195632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Transcription activation of circ-STAT3 induced by Gli2 promotes the progression of hepatoblastoma via acting as a sponge for miR-29a\/b\/c-3p to upregulate STAT3\/Gli2"],"prefix":"10.1186","volume":"39","author":[{"given":"Yanfeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,3]]},"reference":[{"issue":"5","key":"1598_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/pbc.24213","volume":"59","author":"GE Tomlinson","year":"2012","unstructured":"Tomlinson GE, Kappler R. Genetics and epigenetics of hepatoblastoma. Pediatr Blood Cancer. 2012;59(5):785\u201392.","journal-title":"Pediatr Blood Cancer"},{"issue":"5 Suppl 1","key":"1598_CR2","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1053\/j.gastro.2004.09.011","volume":"127","author":"FX Bosch","year":"2004","unstructured":"Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127(5 Suppl 1):S5\u2013s16.","journal-title":"Gastroenterology"},{"key":"1598_CR3","doi-asserted-by":"publisher","unstructured":"Lim IIP, Bondoc AJ, Geller JI, Tiao GM. Hepatoblastoma-the evolution of biology, surgery, and transplantation. Children (Basel, Switzerland). 2018;6(1):1.\u00a0https:\/\/doi.org\/10.3390\/children6010001.","DOI":"10.3390\/children6010001"},{"key":"1598_CR4","doi-asserted-by":"publisher","unstructured":"Kehm RD, Osypuk TL, Poynter JN, Vock DM, Spector LG. Do pregnancy characteristics contribute to rising childhood cancer incidence rates in the United States? Pediatr Blood Cancer. 2018;65(3):10.1002\/pbc.26888. https:\/\/doi.org\/10.1002\/pbc.26888.","DOI":"10.1002\/pbc.26888"},{"issue":"1","key":"1598_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","volume":"18","author":"RL Meyers","year":"2017","unstructured":"Meyers RL, Maibach R, Hiyama E, Haberle B, Krailo M, Rangaswami A, et al. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's hepatic tumors international collaboration. Lancet Oncol. 2017;18(1):122\u201331.","journal-title":"Lancet Oncol"},{"key":"1598_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/HMER.S89997","volume":"9","author":"AD Trobaugh-Lotrario","year":"2017","unstructured":"Trobaugh-Lotrario AD, Meyers RL, O'Neill AF, Feusner JH. Unresectable hepatoblastoma: current perspectives. Hepatic Med : Evid Res. 2017;9:1\u20136.","journal-title":"Hepatic Med : Evid Res"},{"issue":"6","key":"1598_CR7","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1089\/hum.2018.146","volume":"30","author":"X Wang","year":"2019","unstructured":"Wang X, Guo S, Zhao R, Liu Y, Yang G. STAT3-activated long non-coding RNA lung Cancer associated transcript 1 drives cell proliferation, migration, and invasion in Hepatoblastoma through regulation of the miR-301b\/STAT3 Axis. Hum Gene Ther. 2019;30(6):702\u201313.","journal-title":"Hum Gene Ther"},{"issue":"12","key":"1598_CR8","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.7150\/thno.19016","volume":"7","author":"Z Yang","year":"2017","unstructured":"Yang Z, Xie L, Han L, Qu X, Yang Y, Zhang Y, et al. Circular RNAs: regulators of Cancer-related signaling pathways and potential diagnostic biomarkers for human cancers. Theranostics. 2017;7(12):3106\u201317.","journal-title":"Theranostics"},{"issue":"4","key":"1598_CR9","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/15476286.2015.1020271","volume":"12","author":"LL Chen","year":"2015","unstructured":"Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12(4):381\u20138.","journal-title":"RNA Biol"},{"issue":"9","key":"1598_CR10","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1101\/gr.202895.115","volume":"26","author":"XO Zhang","year":"2016","unstructured":"Zhang XO, Dong R, Zhang Y, Zhang JL, Luo Z, Zhang J, et al. Diverse alternative back-splicing and alternative splicing landscape of circular RNAs. Genome Res. 2016;26(9):1277\u201387.","journal-title":"Genome Res"},{"issue":"9","key":"1598_CR11","doi-asserted-by":"publisher","first-page":"e1003777","DOI":"10.1371\/journal.pgen.1003777","volume":"9","author":"J Salzman","year":"2013","unstructured":"Salzman J, Chen RE, Olsen MN, Wang PL, Brown PO. Cell-type specific features of circular RNA expression. PLoS Genet. 2013;9(9):e1003777.","journal-title":"PLoS Genet"},{"key":"1598_CR12","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3389\/fonc.2019.01105","volume":"9","author":"X Wang","year":"2019","unstructured":"Wang X, Wang X, Li W, Zhang Q, Chen J, Chen T. Up-regulation of hsa_circ_0000517 predicts adverse prognosis of hepatocellular carcinoma. Front Oncol. 2019;9:1105.","journal-title":"Front Oncol"},{"issue":"12","key":"1598_CR13","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.7150\/thno.32796","volume":"9","author":"YJ Zhu","year":"2019","unstructured":"Zhu YJ, Zheng B, Luo GJ, Ma XK, Lu XY, Lin XM, et al. Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinoma. Theranostics. 2019;9(12):3526\u201340.","journal-title":"Theranostics"},{"issue":"10","key":"1598_CR14","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.18632\/aging.101988","volume":"11","author":"Y Su","year":"2019","unstructured":"Su Y, Xu C, Liu Y, Hu Y, Wu H. Circular RNA hsa_circ_0001649 inhibits hepatocellular carcinoma progression via multiple miRNAs sponge. Aging. 2019;11(10):3362\u201375.","journal-title":"Aging"},{"issue":"2","key":"1598_CR15","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1159\/000487163","volume":"45","author":"BH Liu","year":"2018","unstructured":"Liu BH, Zhang BB, Liu XQ, Zheng S, Dong KR, Dong R. Expression profiling identifies circular RNA signature in Hepatoblastoma. Cell Physiol Biochem. 2018;45(2):706\u201319.","journal-title":"Cell Physiol Biochem"},{"issue":"3","key":"1598_CR16","doi-asserted-by":"publisher","first-page":"900","DOI":"10.7150\/thno.29515","volume":"9","author":"N Zhen","year":"2019","unstructured":"Zhen N, Gu S, Ma J, Zhu J, Yin M, Xu M, et al. CircHMGCS1 promotes Hepatoblastoma cell proliferation by regulating the IGF signaling pathway and Glutaminolysis. Theranostics. 2019;9(3):900\u201319.","journal-title":"Theranostics"},{"key":"1598_CR17","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.omtn.2019.09.032","volume":"18","author":"X Guan","year":"2019","unstructured":"Guan X, Zong ZH, Liu Y, Chen S, Wang LL, Zhao Y. circPUM1 promotes tumorigenesis and progression of ovarian Cancer by sponging miR-615-5p and miR-6753-5p. Mole Ther Nucleic Acids. 2019;18:882\u201392.","journal-title":"Mole Ther Nucleic Acids"},{"issue":"26","key":"1598_CR18","doi-asserted-by":"publisher","first-page":"8294","DOI":"10.7150\/thno.36256","volume":"9","author":"Z Zhu","year":"2019","unstructured":"Zhu Z, Yu Z, Rong Z, Luo Z, Zhang J, Qiu Z, et al. The novel GINS4 axis promotes gastric cancer growth and progression by activating Rac1 and CDC42. Theranostics. 2019;9(26):8294\u2013311.","journal-title":"Theranostics"},{"key":"1598_CR19","doi-asserted-by":"crossref","unstructured":"Li Y, Li C, Xu R, Wang Y, Li D, Zhang B. A novel circFMN2 promotes tumor proliferation in CRC by regulating the miR-1182\/hTERT signaling pathways. Clin Sci (Lond). 2019;133(24):2463\u201379.\u00a0.","DOI":"10.1042\/CS20190715"},{"issue":"21","key":"1598_CR20","doi-asserted-by":"publisher","first-page":"9689","DOI":"10.18632\/aging.102414","volume":"11","author":"X Dai","year":"2019","unstructured":"Dai X, Guo X, Liu J, Cheng A, Peng X, Zha L, et al. Circular RNA circGRAMD1B inhibits gastric cancer progression by sponging miR-130a-3p and regulating PTEN and p21 expression. Aging. 2019;11(21):9689\u2013708.","journal-title":"Aging."},{"issue":"11","key":"1598_CR21","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1261\/rna.043687.113","volume":"20","author":"P Glazar","year":"2014","unstructured":"Glazar P, Papavasileiou P, Rajewsky N. Circbase: a database for circular RNAs. RNA. 2014;20(11):1666\u201370.","journal-title":"RNA"},{"issue":"Database issue","key":"1598_CR22","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"JH Li","year":"2014","unstructured":"Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(Database issue):D92\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"1598_CR23","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41419-019-1827-3","volume":"10","author":"L Wu","year":"2019","unstructured":"Wu L, Zhang M, Qi L, Zu X, Li Y, Liu L, et al. ERalpha-mediated alterations in circ_0023642 and miR-490-5p signaling suppress bladder cancer invasion. Cell Death Dis. 2019;10(9):635.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1598_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s13046-018-0917-x","volume":"37","author":"D Huang","year":"2018","unstructured":"Huang D, Wang Y, Xu L, Chen L, Cheng M, Shi W, et al. GLI2 promotes cell proliferation and migration through transcriptional activation of ARHGEF16 in human glioma cells. J Exp Clin Cancer Res. 2018;37(1):247.","journal-title":"J Exp Clin Cancer Res"},{"key":"1598_CR25","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.redox.2015.09.025","volume":"5","author":"CA Pena","year":"2015","unstructured":"Pena CA, Gonzalez R, Lopez-Grueso MJ, Antonio BJ. Redox regulation of metabolic and signaling pathways by Thioredoxin and Glutaredoxin in nitric oxide treated Hepatoblastoma cells. Redox Biol. 2015;5:418.","journal-title":"Redox Biol"},{"issue":"1","key":"1598_CR26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13046-017-0614-1","volume":"36","author":"R He","year":"2017","unstructured":"He R, Liu P, Xie X, Zhou Y, Liao Q, Xiong W, et al. CircGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a. J Exp Clin Cancer Res. 2017;36(1):145.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1598_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13046-018-0838-8","volume":"37","author":"N Bai","year":"2018","unstructured":"Bai N, Peng E, Qiu X, Lyu N, Zhang Z, Tao Y, et al. CircFBLIM1 act as a ceRNA to promote hepatocellular cancer progression by sponging miR-346. J Exp Clin Cancer Res. 2018;37(1):172.","journal-title":"J Exp Clin Cancer Res"},{"key":"1598_CR28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13578-018-0269-4","volume":"9","author":"Z Xiao","year":"2019","unstructured":"Xiao Z, Wang Y, Ding H. XPD suppresses cell proliferation and migration via miR-29a-3p-Mdm2\/PDGF-B axis in HCC. Cell Biosci. 2019;9:6.","journal-title":"Cell Biosci"},{"issue":"47","key":"1598_CR29","doi-asserted-by":"publisher","first-page":"4750","DOI":"10.1038\/onc.2011.193","volume":"30","author":"C Braconi","year":"2011","unstructured":"Braconi C, Kogure T, Valeri N, Huang N, Nuovo G, Costinean S, et al. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene. 2011;30(47):4750\u20136.","journal-title":"Oncogene"},{"issue":"3","key":"1598_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s12032-014-0437-2","volume":"32","author":"LL Lin","year":"2015","unstructured":"Lin LL, Wang W, Hu Z, Wang LW, Chang J, Qian H. Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer. Med Oncol. 2015;32(3):39.","journal-title":"Med Oncol"},{"issue":"19","key":"1598_CR31","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1158\/0008-5472.CAN-17-0229","volume":"77","author":"J Ye","year":"2017","unstructured":"Ye J, Li TS, Xu G, Zhao YM, Zhang NP, Fan J, et al. JCAD promotes progression of nonalcoholic Steatohepatitis to liver Cancer by inhibiting LATS2 kinase activity. Cancer Res. 2017;77(19):5287\u2013300.","journal-title":"Cancer Res"},{"issue":"8","key":"1598_CR32","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1158\/0008-5472.CAN-06-3040","volume":"67","author":"Y Kim","year":"2007","unstructured":"Kim Y, Yoon JW, Xiao X, Dean NM, Monia BP, Marcusson EG. Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells. Cancer Res. 2007;67(8):3583\u201393.","journal-title":"Cancer Res"},{"issue":"11","key":"1598_CR33","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1002\/jcb.23240","volume":"112","author":"D Zhang","year":"2011","unstructured":"Zhang D, Liu J, Wang Y, Chen J, Chen T. shRNA-mediated silencing of Gli2 gene inhibits proliferation and sensitizes human hepatocellular carcinoma cells towards TRAIL-induced apoptosis. J Cell Biochem. 2011;112(11):3140\u201350.","journal-title":"J Cell Biochem"},{"issue":"17","key":"1598_CR34","first-page":"3857","volume":"21","author":"JX Wang","year":"2017","unstructured":"Wang JX, Zhou JF, Huang FK, Zhang L, He QL, Qian HY, et al. GLI2 induces PDGFRB expression and modulates cancer stem cell properties of gastric cancer. Eur Rev Med Pharmacol Sci. 2017;21(17):3857\u201365.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"19","key":"1598_CR35","doi-asserted-by":"publisher","first-page":"8182","DOI":"10.18632\/aging.102312","volume":"11","author":"Y Su","year":"2019","unstructured":"Su Y, Lv X, Yin W, Zhou L, Hu Y, Zhou A, et al. CircRNA Cdr1as functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression. Aging. 2019;11(19):8182\u2013203.","journal-title":"Aging."},{"issue":"4","key":"1598_CR36","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s41388-019-1030-0","volume":"39","author":"X Li","year":"2020","unstructured":"Li X, Ding J, Wang X, Cheng Z, Zhu Q. NUDT21 regulates circRNA cyclization and ceRNA crosstalk in hepatocellular carcinoma. Oncogene. 2020;39(4):891\u2013904.","journal-title":"Oncogene."},{"issue":"13","key":"1598_CR37","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1042\/CS20190394","volume":"133","author":"J Yu","year":"2019","unstructured":"Yu J, Yang M, Zhou B, Luo J, Zhang Z, Zhang W, et al. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p\/TXNDC5 signaling pathway. Clin Sci(Lond). 2019;133(13):1487\u2013503.","journal-title":"Clin Sci(Lond)"},{"issue":"1","key":"1598_CR38","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13046-019-1041-2","volume":"38","author":"L Xu","year":"2019","unstructured":"Xu L, Feng X, Hao X, Wang P, Zhang Y, Zheng X, et al. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth. J Exp Clin Cancer Res. 2019;38(1):98.","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-020-01598-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-020-01598-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-020-01598-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T02:20:49Z","timestamp":1622686849000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-020-01598-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,3]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1598"],"URL":"https:\/\/doi.org\/10.1186\/s13046-020-01598-8","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,3]]},"assertion":[{"value":"7 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethic committee of Qilu Hospital of Shandong University. Informed consent was obtained from each participant.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Authors confirmed that this work can be published. The content of this manuscript is original and it has not yet been accepted or published elsewhere.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that no competing interest exists in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}